Panos Hatsis, Ph.D.

Director Drug Metabolism and Pharmacokinetics
Nido Biosciences, Inc.

Poster(s):

• (T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
  Tuesday, October 22, 2024

  10:30 AM – 11:30 AM MT